Can facet joint block be a complementary or alternative therapeutic option for patients with osteoporotic vertebral fractures: a meta-analysis

Table 1 The baseline characteristics of included studies

References	Year	Country	Study	Anesthetic agent	Treatment	Patients	Age	Sex(M/F)	Control	Patients	Age	Sex(M/F)	Follow up	Quality
Tao [18]	2020	China	Cohort study	Lidocaine	PKP + FJB	31	74.48	10/21	PKP	29	77.52	11/19	1 mon	H
Zhang [17]	2018	China	Cohort study	Lidocaine + steroid	PKP + FJB	56	NA	NA	PKP	56	NA	NA	3 mon	H
Li [16]	2016	China	Cohort study	Lidocaine + steroid	PVP + FJB	19	84.6	5/14	PVP	23	85.7	7/16	4–18 mon	H
Zhang [15]	2021	China	RCT	Lidocaine + steroid	PVP + FJB	34	78.32	19/14	PVP	34	78.65	20/14	6 mon	L
Wang [14]	2019	China	Cohort study	Lidocaine + steroid	PKP + FJB	36	76.14	15/21	PKP	36	75.86	14/22	1 mon	H
Li [10]	2021	China	Cohort study	Ropivacaine + steroid + vitamin B12	PKP + FJB	83	65.3	29/54	PKP	88	66.8	32/56	12 mon	H
Cheng [7]	2020	China	Cohort study	Lidocaine + steroid	PKP + FJB	79	72.9	12/67	PKP	125	70.8	25/100	12 mon	H
Luo [19]	2020	China	Cohort study	Lidocaine + mecobalamin	FJB	23	75.79	5/18	PKP	23	75.47	4/19	12 mon	H
Wang [8]	2016	China	RCT	Lidocaine + steroid	FJB	106	62.59	22/84	PVP	100	63.68	19/81	12 mon	H
Bae [9]	2018	USA	Cohort study	Lidocaine + steroid	FJB	72	73.1	19/53	PVP	92	76.7	24/68	24 mon	H

RCT, randomized controlled trial; PKP, percutaneous kyphoplasty; PVP, percutaneous vertebroplasty; FJB, facet joint block; NA, not available; Mon, month; H, high; L, low

ISSN: 1749-799X